and recommendation

Brainstorm Cell Therapeutics Inc. (BCLI)
Brainstorm Cell Therapeutics Inc., a biotechnology company, engages in developing adult stem cell therapies for neurodegenerative disorders, such as amyotrophic lateral sclerosis (ALS), Parkinsons disease, and multiple sclerosis. It holds rights to develop and commercialize its NurOwn technology through a worldwide licensing agreement with Ramot, the technology transfer company of the Tel Aviv University.
BCLI's NurOwn technology, an autologous adult stem cell therapy technology that differentiates bone marrow-derived mesenchymal stem cells into specialized neuron-supporting cells. It also has agreements with Hadasit Medical Research Services and Development Ltd. to conduct its ALS clinical trials at the Hadassah Medical Center.
Brainstorm Cell Therapy was formerly known as Golden Hand Resources Inc. and changed its name to Brainstorm Cell Therapeutics Inc. in November 2004. BCLI was founded in 2000 and is based in New York, New York.
- May 17, 2014 - 1:27pm | Earnings
- April 28, 2014 - 8:11am | Research Notes
- April 27, 2014 - 11:38am | Financings
- April 10, 2014 - 10:43am | Regulatory
- March 25, 2014 - 9:07am | Regulatory
- March 24, 2014 - 8:15am | IP & Patents
- March 11, 2014 - 10:45pm | Earnings, Earnings Q4
- February 25, 2014 - 9:46am | Financings
- February 23, 2014 - 3:20pm
- February 3, 2014 - 9:02am | IP & Patents
- January 13, 2014 - 11:15am | Research Notes
- November 16, 2013 - 6:54pm | Research Notes
- October 15, 2013 - 10:29am | Research Notes
- August 13, 2013 - 9:39am | Financings
- August 1, 2013 - 11:21am | Research Notes, Regulatory
- July 29, 2013 - 9:10am | Research Notes, Regulatory
- June 26, 2013 - 9:40pm | Out and About
- June 10, 2013 - 7:33am | Research Notes, Regulatory
- June 5, 2013 - 7:54am | Research Notes
- June 4, 2013 - 8:41pm | Out and About